On February 23, 2024, Joseph B. Spears notified Omnicell, Inc. that he will retire and depart from the Company, effective May 31, 2024. In addition, effective March 18, 2024, Omnicell has hired Brian Nutt, age 54, to serve as Vice President, Chief Accounting Officer, of the Company. Upon Mr. Nutt joining the Company, Mr. Nutt will also be designated Corporate Controller and principal accounting officer of the Company for purposes of the Company?s filings with the U.S. Securities and Exchange Commission.

Accordingly, upon Mr. Nutt joining the Company, Mr. Spears will step down from his positions as Senior Vice President, Chief Accounting Officer of the Company. Mr. Spears will also cease serving as the Company?s Corporate Controller and principal accounting officer upon Mr. Nutt?s appointment. Following Mr. Spears stepping down from his positions, he will remain with the Company in an executive adviser capacity to assist with the transition of his roles and responsibilities until the Spears Retirement Date.

Prior to joining Omnicell, since February 2015, Mr. Nutt served as Vice President and Controller, Labcorp Drug Development Segment of Laboratory Corporation of America Holdings, a leading global life sciences company. From May 2011 to February 2015, Mr. Nutt served as Chief Accounting Officer of Covance Inc. (?Covance?), a leading drug development services company. Prior thereto he held senior finance roles from August 2006 to May 2011 at Covance.

Prior to Covance, Mr. Nutt served as Senior Director, Financial Reporting and Internal Audit of MedPointe Inc., a specialty pharmaceutical company, from December 2001 to August 2006. From May 1995 to December 2001, Mr. Nutt held various finance roles of increasing responsibility at Carter-Wallace, Inc., Voxware, Inc., and Princeton eCom, Inc. He started his career with KPMG LLP in Princeton, NJ. Mr. Nutt received a Bachelor of Science degree in business administration ?

accounting and an MBA in finance from Rider University.